Brett Fishbin

Stock Analyst at Keybanc

(2.07)
# 3,118
Out of 5,182 analysts
52
Total ratings
41.3%
Success rate
-3.97%
Average return

Stocks Rated by Brett Fishbin

Solventum
Apr 27, 2026
Maintains: Overweight
Price Target: $99$92
Current: $68.53
Upside: +34.26%
ResMed
Apr 27, 2026
Maintains: Overweight
Price Target: $302$290
Current: $220.63
Upside: +31.44%
ICU Medical
Apr 27, 2026
Maintains: Overweight
Price Target: $180$164
Current: $121.74
Upside: +34.71%
LivaNova
Dec 19, 2025
Initiates: Overweight
Price Target: $81
Current: $62.71
Upside: +29.17%
Integer Holdings
Oct 24, 2025
Maintains: Overweight
Price Target: $133$93
Current: $84.65
Upside: +9.86%
Alcon
Oct 21, 2025
Maintains: Overweight
Price Target: $98$91
Current: $75.43
Upside: +20.64%
Inspire Medical Systems
Aug 5, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $55.61
Upside: -
STERIS
Jul 22, 2025
Maintains: Overweight
Price Target: $277$288
Current: $221.09
Upside: +30.26%
Texas Instruments
Apr 24, 2025
Maintains: Overweight
Price Target: $250$215
Current: $267.76
Upside: -19.70%
UFP Technologies
Feb 6, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $199.22
Upside: -
Initiates: Sector Weight
Price Target: n/a
Current: $15.57
Upside: -
Initiates: Sector Weight
Price Target: n/a
Current: $113.23
Upside: -
Initiates: Sector Weight
Price Target: n/a
Current: $63.34
Upside: -